Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Coagulation factor X

Coagulation factor X

Brief Information

Name:Coagulation factor X
Target Synonym:EC 3.4.21,EC:3.4.21.6,Stuart factor,Coagulation factor X,F10,Stuart-Prower Factor,Prothrombinase,EC 3.4.21.6,Factor Xa,Factor X,FXA,FX
Number of Launched Drugs:112
Number of Drugs in Clinical Trials:55
Lastest Research Phase:Approved

Product Inquiry

* We couldn't find what you're looking for. You can let us help by filling the form below. Our tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information will be kept strictly confidential.
Product inquiry collection form
*
*
*
*
*
*
*
*
*
ACRO Quality

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Rurioctocog alfa BLB-200; rAHF-PFM Approved Baxalta Incorporated 百因止, Advate United States Hemophilia A null 2003-07-25 Hemophilia A Details
Enoxaparin Sodium PRY-005; PK-10169; XRP-4563K; M-enoxaparin; RP-54563; RPY-005 Approved Sanofi Klexane, 克赛, Lovenox, Clexane, Enoxamed United States Pulmonary Embolism; Venous Thrombosis Sanofi-Aventis U.S. Llc 1993-03-29 Lung Neoplasms; Respiratory Distress Syndrome, Adult; Liver Diseases; Thromboembolism; Pre-Eclampsia; Coronary Disease; Coronavirus Infections; Fetal Growth Retardation; Cardiovascular Diseases; Venous Thrombosis; Hypoxia; Obstetric Labor, Premature; Nephrotic Syndrome; Thrombophilia; Intraoperative Complications; Postoperative Complications; Thrombosis; Carcinoma, Non-Small-Cell Lung; Catheter-Related Infections; Non-ST Elevated Myocardial Infarction; Brain Injuries, Traumatic; Ovarian Neoplasms; Myocardial Ischemia; Venous Thromboembolism; ST Elevation Myocardial Infarction; Myocardial Infarction; Esophageal Neoplasms; Stomach Neoplasms; Abdominal Neoplasms; Angina, Unstable; Pulmonary Embolism; Kidney Diseases; Colonic Neoplasms; Neoplasms; Coronavirus Disease 2019 (COVID-19); Obesity, Morbid; Pancreatic Neoplasms; Hip Fractures; Virus Diseases; Acute Coronary Syndrome Details
Enoxaparin sodium biosimilar (Gland Pharma) Approved Gland Pharma Ltd Cutenox Angina, Unstable; Myocardial Infarction; Venous Thromboembolism; Venous Thrombosis Gland Pharma 2014-10-01 Angina, Unstable; Myocardial Infarction; Venous Thromboembolism; Venous Thrombosis Details
Human coagulation factor Ⅷ (Chengdu Rongsheng Pharmaceuticals) Approved Chengdu Rongsheng Pharmaceuticals Co Ltd Mainland China Hemophilia A Chengdu Rongsheng Pharmaceuticals Co Ltd 2001-01-01 Hemophilia A Details
Von Willebrand factor/coagulation factor VIII complex (human, Octapharma) Approved Octapharma Wilate, Eqwilate, Wilnativ Germany Hemophilia A; von Willebrand Diseases Octapharma 2005-01-01 von Willebrand Diseases; Hemophilia A Details
Human coagulation factor VIII (China Biologic Products) Approved Taibang Biotech (Shandong) Co Ltd Mainland China Hemophilia A Taibang Biotech (Shandong) Co Ltd 2012-06-15 Hemophilia A; Hemorrhage; Blood Loss, Surgical Details
Enoxaparin sodium biosimilar (Apotex Pty Ltd) Approved Apotex Australia Myocardial Ischemia; Angina, Unstable; Venous Thromboembolism; Thrombosis; Venous Thrombosis Apotex 2020-02-10 Myocardial Ischemia; Angina, Unstable; Venous Thromboembolism; Venous Thrombosis; Thrombosis Details
Anti-inhibitor coagulant complex (Baxalta) Approved Baxalta Incorporated PROPLEX 600, Prothromplex, Prothromplex 600, Prothromplex 600 IE, Prothromplex 600 SV, Prothromplex 600 TV, Prothromplex 600 UI, Prothromplex NF 600, PROPLEX, Feiba, Prothromplex TOTAL United States Hemophilia B; Hemophilia A Baxalta Incorporated 1979-12-21 Blood Coagulation Disorders; Blood Coagulation Disorders, Inherited; Hemophilia A; Hemophilia B; Cardiovascular Diseases Details
Apixaban BMS-562247-01; BMS-562247; TAH-3311 Approved Bristol-Myers Squibb Company Eliquis, 艾乐妥, 艾乐通 EU Venous Thromboembolism Bristol-Myers Squibb/Pfizer Eeig 2011-05-18 Thrombocytopenia; Atrial Fibrillation; Ischemic Attack, Transient; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Aortic Valve Insufficiency; Astrocytoma; Primary Myelofibrosis; Colitis, Ulcerative; Ischemic Stroke; Colonic Diseases; Genital Neoplasms, Female; Lymphoma; Glomerulonephritis, Membranous; Venous Thrombosis; Aortic Valve Stenosis; Nephrotic Syndrome; Thrombosis; Kidney Failure, Chronic; Thrombocythemia, Essential; Rectal Diseases; Crohn Disease; Fasting; Anemia, Sickle Cell; Pancreatic Neoplasms; Pulmonary Embolism; Embolism; Hematologic Neoplasms; Solid tumours; Venous Thromboembolism; Cerebral Hemorrhage; Spinal Cord Injuries; Inflammatory Bowel Diseases; Polycythemia Vera; Foramen Ovale, Patent; Atrial Flutter; Bone Marrow Neoplasms; Aortic valve diseases; Myeloproliferative Disorders; Glioblastoma; Neoplasms; Coronavirus Disease 2019 (COVID-19); Proteinuria; Acute Coronary Syndrome; Stroke; Thromboembolism; Hemorrhage Details
Turoctocog alfa NNC0155-0000-0004; NN-7008 Approved Novo Nordisk A/S Zonovate, Novoeight United States Hemophilia A null 2013-10-15 Hemophilia A; Hemorrhage Details
Human prothrombin complex (Nanyue Biopharming) Approved Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd Mainland China Hemorrhage Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd 2019-09-05 Hemophilia B; Hemorrhage Details
Human Antithrombin III (Hemarus Therapeutics) Approved Hemarus Therapeutics India Antithrombin III Deficiency Hemarus Therapeutics 2015-08-01 Antithrombin III Deficiency Details
Enoxaparin sodium biosimilar (Techdow) Approved Shenzhen Techdow Pharmaceutical Co Ltd Inhixa Mainland China Embolism and Thrombosis Shenzhen Techdow Pharmaceutical Co Ltd 2005-08-18 Pulmonary Embolism; Blood Coagulation Disorders; Venous Thromboembolism; Angina, Unstable; Coronavirus Disease 2019 (COVID-19); Embolism and Thrombosis; Coronavirus Infections; Pneumonia, Viral; Venous Thrombosis; Non-ST Elevated Myocardial Infarction Details
Moroctocog alfa PF-05208756; r-VIII SQ; PF-5208756; r-Factor VIII SQ; BDDrFVIII Approved Pfizer Inc ReFacto, Xyntha, Refacto AF, Xyntha Solofuse, Refacto AF/Xyntha, 任捷 EU Hemophilia A Pfizer Europe Ma Eeig 1999-04-13 Hemophilia A Details
Heparin sodium biosimilar (Chandra Bhagat Pharma) Approved Chandra Bhagat Pharma(Cbc) Thromboparin India Thrombosis Chandra Bhagat Pharma(Cbc) 2012-08-01 Thrombosis Details
Factor VIII (Tonrol Biopharmaceuticals) Hemorass Approved Tonrol Bio-Pharmaceutical Co Ltd HEMORAAS Hemophilia A Details
Danaparoid sodium KB-101; Org-10172 Approved Merck Sharp & Dohme Corp, Organon Orgaran, Lomoparan Netherlands Thrombocytopenia; Venous Thromboembolism null 1991-01-01 Venous Thromboembolism; Thrombocytopenia; Venous Thrombosis Details
Eptacog alfa (Novo Nordisk) NN-007 Approved Novo Nordisk A/S NiaStase, NovoSeven, 诺其 EU Thrombasthenia; Factor VII Deficiency; Hemophilia A; Hemophilia B Novo Nordisk A/S 1996-02-23 Cerebral Hemorrhage; Spinal Diseases; Hemophilia A; Hemophilia B; Liver Cirrhosis; Hemorrhage; Stroke; Postpartum Hemorrhage; Factor VII Deficiency; Severe Dengue; Burns; Blood Loss, Surgical; Wounds and Injuries; Thrombasthenia; Acquired hemophilia Details
Human prothrombin complex (CSL Behring) BE-1116 Approved Csl Behring Llc Kcentra, Beriplex, Confidex Japan Vitamin K Deficiency Bleeding Csl Behring Kk Coagulation Protein Disorders; Blood Coagulation Disorders; Vitamin K Deficiency Bleeding; Heart Failure; Heart Diseases; Hemorrhage; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Wounds and Injuries Details
Freeze-dried activated human blood coagulation factor Ⅶ concentrate containing factor Ⅹ (Kaketsuken/KM Biologics) MC-710 Approved KM Biologics Co Ltd Byclot Japan Hemophilia A null 2014-07-04 Hemophilia A Details
Trenonacog alfa IB-1001; APVO-101 Approved Inspiration Biopharmaceuticals Ixinity United States Hemophilia B null 2015-05-14 Hemophilia B Details
Human prothrombin complex concentrate (Guizhou Taibang Biological Products) Approved Guizhou Taibang Biological Products Co Ltd Mainland China Hypoprothrombinemias Guizhou Taibang Biological Products Co Ltd 2013-07-31 Hypoprothrombinemias Details
Factor VIII (CSL) Approved Csl Ltd Beriate Sweden Hemophilia A Csl Behring Gmbh 1997-06-06 Hemophilia A Details
Enoxaparin sodium biosimilar (PT Kalbe) Approved Kalbe Farma Kalbenox Cambodia Myocardial Infarction; Venous Thrombosis; Angina, Unstable Kalbe Farma 2012-01-01 Myocardial Infarction; Angina, Unstable; Venous Thrombosis Details
Rivaroxaban JNJ-39039039; BAY-59-7939; YHP-1807; YHR-1901 Approved Bayer AG, Johnson & Johnson Pharmaceutical Research & Development LLC Xarelto, 拜瑞妥 Canada Atherosclerosis Bayer AG 2008-09-15 Intraoperative Complications; Antiphospholipid Syndrome; Coronary Disease; Atrial Fibrillation; Osteoarthritis, Knee; Rheumatic Heart Disease; Rheumatic Diseases; Cardiovascular Diseases; Urologic Neoplasms; Venous Thrombosis; Thrombocytopenia; Arthritis; Hemorrhage; Renal Insufficiency, Chronic; Postoperative Complications; Obesity; Thrombosis; Heart Defects, Congenital; Peripheral Arterial Disease; Osteoarthritis, Hip; Respiratory Insufficiency; Kidney Failure, Chronic; Anemia, Sickle Cell; Communicable Diseases; Myocardial Ischemia; Embolism; Upper Extremity Deep Vein Thrombosis; Heart Failure; Angina, Unstable; Venous Thromboembolism; Myocardial Infarction; Mitral Valve Stenosis; Atherosclerosis; Diabetes Mellitus, Type 2; Pulmonary Embolism; Arterial Occlusive Diseases; Coronary Artery Disease; Coronavirus Disease 2019 (COVID-19); Neoplasms; Obesity, Morbid; beta-Thalassemia; Thromboembolism; Stroke; Acute Coronary Syndrome; Embolism and Thrombosis Details
Human Coagulation Factor Ⅷ (Hualan Biological Engineering) Approved Hualan Genetic Engineering Co Ltd 康斯平, Kangsiping Mainland China Blood Coagulation Disorders; Hemophilia A Hualan Biological Engineering Inc 2000-01-01 Blood Coagulation Disorders; Hemophilia A Details
Antithrombin III (Human, Grifols) Approved Grifols Sa Thrombate III United States Thromboembolism; Antithrombin III Deficiency null 1991-12-30 Venous Thromboembolism; Coronavirus Disease 2019 (COVID-19); Liver Cirrhosis; Heart Diseases; Thromboembolism; Antithrombin III Deficiency; Wounds and Injuries; Postoperative Complications; Venous Thrombosis Details
Susoctocog alfa BAX-801; OBI-1; TAK-672; SHP-672; BAX-802 Approved Baxalta Incorporated Obizur United States Hemophilia A null 2014-10-23 Hemophilia A; Hemorrhage; Acquired hemophilia Details
Enoxaparin sodium biosimilar (Neiss Labs) Approved Neiss Labs Lomonox India Venous Thrombosis Neiss Labs 2012-08-01 Venous Thrombosis Details
Certoparin sodium Approved Novartis Pharma Ag Troparin, Alphaparin, Sandoparin, Sandoparine, Mono-Embolex Pulmonary Embolism; Thromboembolism; Venous Thrombosis null 1997-01-01 Embolism; Pulmonary Embolism; Renal Insufficiency; Kidney Diseases; Thromboembolism; Atrial Fibrillation; Venous Thrombosis Details
Parnaparin sodium OP-2123; CB-01-05 Approved Opocrin Spa, Alfasigma Spa Fluxum, Lowhepa, Minidalton Italy Thrombosis null 1993-01-01 Thrombophlebitis; Infertility; Thrombosis Details
Octocog alfa BAY14-2222 Approved Bayer AG Kogenate, Helixate NexGen, Kovaltry, Iblias, Kogenate/Kovaltry, 科跃奇 United States Hemophilia A Bayer Healthcare 1993-02-25 Blood Coagulation Disorders; Hemophilia A Details
Moroctocog alfa biosimilar (International Biotech Center Generium) GNR-002 Approved International Biotech Center Generium Octofactor Russian Federation Hemophilia A International Biotech Center Generium 2013-01-01 Hemophilia A Details
Antihemophilic factor/von Willebrand factor (CSL Behring) Approved Csl Behring Llc Aleviate, Voncento, Humate-P, Biostate, Haemate P United States von Willebrand Diseases; Hemophilia A null 1999-04-01 von Willebrand Diseases; Hemophilia A Details
Antihemophilic factor B (Armour) Approved Csl Behring Llc, Armour Pharma MonoFIX, Mononine Hemophilia B null 1993-05-01 Hemophilia B Details
Ardeparin sodium Approved Wyeth-Ayerst Normiflo United States Pulmonary Embolism; Venous Thrombosis null 1997-05-01 Pulmonary Embolism; Venous Thrombosis Details
Dalteparin Sodium FR-860; KV-165; KABI-2165 Approved Pfizer Inc 法安明, Fragmin Germany Thrombosis Pfizer Inc 1985-01-01 Puerperal Disorders; Thrombosis; Anemia, Sickle Cell; Thrombophilia; Venous Thrombosis; Lung Neoplasms; Pregnancy Complications; Colorectal Neoplasms; Parturition; Brain Neoplasms; Atrial Fibrillation; Hepatic Veno-Occlusive Disease; Prostatic Neoplasms; Breast Neoplasms; Diabetic Foot; Abortion, Habitual; Thromboembolism; Central Nervous System Neoplasms; Stroke; Coronary Artery Disease; Neoplasms; Renal Insufficiency; Angina, Unstable; Myocardial Infarction; Brain Injuries, Traumatic; Venous Thromboembolism; Ovarian Neoplasms; Pulmonary Embolism Details
Turoctocog alfa pegol NN-7088; N8-GP; N8-GP-rFVIII; NNC-0129-0000-1003 Approved Novo Nordisk A/S Esperoct United States Hemophilia A Novo Nordisk Inc 2019-02-19 Hemophilia A; Hemorrhage Details
NecLip-pdFVIII pdFVIII Approved Recoly Nv LongAte, LongEight Hemophilia A Details
Prothrombinex-VF (CSL Behring) Approved Csl Behring Llc Australia Hemorrhage Csl Behring Llc 2014-10-01 Hemorrhage Details
Factor VIII (Shanxi Kangbao Biological Products) Approved Shanxi Kangbao Biological Product Co Ltd Mainland China Hemophilia A Shanxi Kangbao Biological Product Co Ltd 2020-08-14 Hemophilia A Details
Factor VIII biosimilar (Chia Tai-Tianqing) KN-008 Approved Suzhou Alphamab Co Ltd, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd 安恒吉 Mainland China Hemophilia A Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group 2023-08-29 Hemophilia A Details
Recombinant Human Coagulation Factor VIII (sinocelltech) SCT-800 Approved SinoCelltech Ltd Mainland China Hemophilia A SinoCelltech Ltd 2021-07-20 Hemophilia A; Blood Loss, Surgical Details
Efmoroctocog alfa BIIB-031; rFVIIIFc Approved Biogen Inc, Sobi, Bioverativ Inc Elocta, Eloctate United States Hemophilia A null 2014-06-06 Hemophilia A Details
Efanesoctocog alfa BIVV-001; BIVV001 Approved Amunix Pharmaceuticals Inc Altuviiio United States Hemophilia A Sanofi 2023-02-23 von Willebrand Diseases; Hemophilia A Details
Lonoctocog alfa CSL-627; NBP-601 Approved Sk Chemicals, Csl Behring Llc Afstyla United States Hemophilia A Csl Behring Ag 2016-05-25 Hemophilia A Details
Antihemophilic Factor (Recombinant) Approved Baxalta Incorporated Recombinate United States Hemophilia A null 1992-12-10 Hemophilia A Details
Prothrombin complex concentrate (Sanquin) Approved Sanquin Plasma Products Bv Cofact Hemorrhage Sanquin Plasma Products Bv 2007-11-01 Hemorrhage Details
Enoxaparin sodium biosimilar (Rovi) Approved Rovi Arovi Angina, Unstable; Myocardial Infarction; Venous Thrombosis Rovi 2018-03-31 Angina, Unstable; Myocardial Infarction; Venous Thrombosis Details
Emicizumab RG-6013; ACE-910; RO-5534262 Approved Genentech Inc, Chugai Pharmaceutical Co Ltd 舒友立乐, Hemlibra United States Hemophilia A Genentech Inc 2017-11-16 Hemophilia A; Hemorrhage; von Willebrand Disease, Type 3 Details
Human Coagulation Factor IX (Hemarus Therapeutics) Approved Hemarus Therapeutics Clotnine India Hemophilia B Hemarus Therapeutics 2015-08-01 Hemophilia B Details
Human Coagulation Factors IX and X (CSL Behring) Approved Csl Behring Llc Factor X P Behring Hemophilia B Details
Enoxaparin sodium biosimilar (Blau Pharmaceuticals) Approved Blau Pharmaceuticals Enoxalow Thrombosis Blau Pharmaceuticals 2013-07-01 Thrombosis Details
Nonacog alfa rh-F-IX; rh-Factor-IX Approved Pfizer Inc 贝赋, BeneFIX EU Hemophilia B Pfizer Europe Ma Eeig 1997-08-27 Hemophilia B Details
Eptacog alfa biosimilar (AryoGen Biopharma) Approved Aryogen Biopharma Iran Factor VII Deficiency; Hemophilia A; Hemophilia B; Thrombasthenia Aryogen Biopharma 2014-01-01 Hemophilia A; Hemophilia B; Factor VII Deficiency; Thrombasthenia Details
Nonacog alfa (International Biotech Center Generium) GNR-003 Approved International Biotech Center Generium Innonafactor Russian Federation Hemophilia B International Biotech Center Generium 2014-01-01 Hemophilia B Details
Factor IX complex (Grifols) Approved Grifols Sa Profilnine United States Hemophilia B null 1981-07-21 Intracranial Hemorrhages; Hemophilia B Details
Edoxaban Tosilate Hydrate DU-176b Approved Daiichi Sankyo Co Ltd Savaysa, 里先安, Roteas, Lixiana, Lixiana/Savaysa Japan Pulmonary Embolism; Embolism; Stroke; Venous Thromboembolism; Venous Thrombosis Daiichi Sankyo Co Ltd 2011-04-22 Embolism and Thrombosis; Thrombosis; Obesity; Inflammation; Aortic Valve Stenosis; Venous Thrombosis; Osteoarthritis, Knee; Ischemic Stroke; Atrial Fibrillation; Pulmonary Embolism; Stroke; Thromboembolism; Neoplasms; Heart Diseases; Venous Thromboembolism; HIV Infections; Embolism Details
Nonacog beta pegol N9-GP; NN-7999; 40K-PEG-rFIX; NNC-0156-0000-0009 Approved Novo Nordisk A/S Rebinyn, Refixia United States Hemophilia B Novo Nordisk Inc 2017-05-31 Hemophilia B; Hemorrhage Details
Human coagulation factor VIII (Green Cross Biological Products) Approved GC Biopharma Corp Mainland China Blood Coagulation Disorders Green Cross China Biological Products Co Ltd 2000-01-01 Blood Coagulation Disorders Details
Enoxaparin sodium biosimilar (Harvest Moon Pharmaceuticals) Approved Harvest Moon Angina, Unstable; Myocardial Infarction; Venous Thromboembolism; Venous Thrombosis Details
Eptacog beta LR-769; rhFVIIa Approved Lfb Biotechnologies Sas, Revo Biologics Inc Sevenfact United States Hemophilia A; Hemophilia B Lfb Biotechnologies Sas 2020-04-01 Hemophilia A; Hemophilia B Details
Simoctocog alfa Factor VIII; Human-cl rhFVIII Approved Octapharma Vihuma, Nuwiq EU Hemophilia A Octapharma Ab 2014-07-22 Hemophilia A Details
Human prothrombin complex (Octapharma) Approved Octapharma Ocplex, Octaplex, Pronativ Germany Hemorrhage Octapharma 2003-03-14 Hemorrhage; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Details
Nonacog gamma rFIX; BAX-326 Approved Baxalta Incorporated Rixubis United States Hemophilia B null 2013-06-26 Hemophilia B Details
Factor VIII/von Willebrand factor (Bio Products Laboratory) Approved Bio Products Laboratory Ltd Optivate Hemophilia A Bio Products Laboratory Ltd 2004-12-01 von Willebrand Diseases; Hemophilia A Details
Eptacog alfa biosimilar (International Biotech Center Generium) GNR-001 Approved International Biotech Center Generium Russian Federation Hemophilia A International Biotech Center Generium 2015-01-01 Hemophilia A Details
Antihemophilic factor/von Willebrand factor complex (Human, Grifols Biologicals) Approved Grifols Sa Alphanate United States Hemophilia A; von Willebrand Diseases null 1978-08-15 von Willebrand Diseases; Hemophilia A Details
Rurioctocog alfa pegol BAX-0855; BAX-855; TAK-660 Approved Baxalta Incorporated, Nektar Therapeutics Adynovi, Adynovate United States Hemophilia A null 2015-11-13 Hemophilia A Details
Human prothrombin complex (LFB) Approved Lfb Biotechnologies Sas KANOKAD France Hemorrhage Lfb Biotechnologies Sas 2008-09-01 Hemorrhage Details
Eftrenonacog Alfa BIIB-029; FIX:Fc; FIXFc; rFIXFc Approved Sobi, Biogen Inc, Bioverativ Inc Alprolix, 赛玖凝 United States Hemophilia B null 2014-03-28 Hemophilia B Details
Factor VIII (Intas Pharmaceuticals) Approved Intas Biopharmaceuticals Factocel VIII Hemophilia A Details
Moroctocog alfa biosimilar (Amega Biotech) Approved Amega Biotech Argentina Hemophilia A Amega Biotech 2012-01-01 Hemophilia A Details
Fondaparinux Sodium GSK-576428; Org-31540; SR-90107; SR-90107A Approved Organon Arixtra, Quixidar, 安卓 United States Venous Thrombosis; Liver Diseases; Pulmonary Embolism Mylan Ireland Ltd 2001-12-07 Angina Pectoris; Uterine Cervical Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Venous Thrombosis; Sarcoma; Vulvar Neoplasms; Atrial Fibrillation; Coronary Disease; Liver Diseases; Pulmonary Embolism; Thromboembolism; Obesity, Morbid; Neoplasms; Vaginal Neoplasms; Renal Insufficiency; Venous Thromboembolism; Angina, Unstable; Myocardial Infarction; Ovarian Neoplasms Details
Enoxaparin sodium biosimilar (Chandra Bhagat Pharma) Approved Chandra Bhagat Pharma(Cbc) MAXIPARINE Venous Thrombosis Details
Antithrombin III (CSL Behring) BI51.017 Approved Csl Behring Llc Kybernin, Anthrobin, Athimbin Japan Thrombosis; Disseminated Intravascular Coagulation Csl Behring Llc 1987-08-02 Disseminated Intravascular Coagulation; Thrombosis Details
Heparin sodium biosimilar (Blau Pharmaceuticals) Approved Blau Pharmaceuticals Hepamax-S Brazil Thrombosis Blau Pharmaceuticals 2012-08-01 Thrombosis Details
Human prothrombin complex (Tonrol Biopharmaceuticals) Approved Tonrol Bio-Pharmaceutical Co Ltd ProthoRAAS Mainland China Hemorrhage Shanghai Raas Blood Products Co Ltd 1996-01-01 Hemophilia B; Hemorrhage Details
Human Coagulation Factor VIII (Hemarus Therapeutics) Approved Hemarus Therapeutics CLOTATE India Hemophilia A Hemarus Therapeutics 2015-08-01 Hemophilia A Details
Human factor IX (LFB) Approved Lfb Biotechnologies Sas Betafact Netherlands Hemophilia B Lfb Biotechnologies Sas 2000-05-01 Hemophilia B Details
Albutrepenonacog alfa CSL-640; CSL-654 Approved Csl Behring Llc Idelvion United States Hemophilia B null 2016-03-04 Hemophilia B Details
Enoxaparin sodium biosimilar (Fresenius Kabi) Approved Fresenius Kabi Canada Ltd ELONOX, ELONOX HP Canada Thromboembolism; Venous Thrombosis Fresenius Kabi Canada Ltd 2022-10-26 Thromboembolism; Venous Thrombosis Details
Recombinant Human Coagulation Factor Ⅷ (Chengdu Rongsheng Pharmaceuticals) Approved Chengdu Rongsheng Pharmaceuticals Co Ltd Mainland China Hemophilia A Chengdu Rongsheng Pharmaceuticals Co Ltd 2023-09-05 Hemophilia A Details
Human prothrombin complex (ShenzhenWeiguang Biological Products) Approved Shenzhen Weiguang Biological Products Co Ltd Mainland China Hemorrhage Shenzhen Weiguang Biological Products Co Ltd 2024-05-21 Hemophilia B; Hemorrhage Details
Human prothrombin complex (Guangdong Shuanglin) Approved Guangdong Shuanglin Bio-Pharmaceutical Co Ltd Mainland China Hemophilia B Guangdong Shuanglin Bio-Pharmaceutical Co Ltd 2023-05-12 Hemophilia B Details
Human coagulation factor Ⅷ (Shanghai Xinxing) Approved Shanghai Xinxing Medicine Co Ltd Mainland China Hemophilia A; Hemorrhagic Disorders Shanghai Xinxing Medicine Co Ltd 2015-07-27 Hemorrhagic Disorders; Hemophilia A Details
Human coagulation factor Ⅷ (Shanghai Institute of Biological Products) Approved Shanghai Institute Of Biological Products Co Ltd Mainland China Hemorrhagic Disorders; Hemophilia A Shanghai Institute Of Biological Products Co Ltd 2012-07-23 Hemorrhagic Disorders; Hemophilia A Details
Human coagulation factor Ⅷ (Shandong Taibang) Approved Shandong Taibang Biological Products Co Ltd Mainland China Shandong Taibang Biological Products Co Ltd 2012-06-15 Details
Human Coagulation Factor Ⅷ (Sinopharm Shanghai Plasma) Approved Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd Mainland China Hemophilia A Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd 2012-07-23 Hemophilia A Details
Human prothrombin complex (Shanghai Xinxing) Approved Shanghai Xinxing Medicine Co Ltd Mainland China Hemorrhage Shanghai Xinxing Medicine Co Ltd 1997-01-01 Hemorrhage Details
Human prothrombin complex (Sinopharm Shanghai Plasma) Approved Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd Mainland China Hemorrhage Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd 1997-01-01 Hemorrhage Details
Human prothrombin complex (Boya Bio-Pharmaceutical) Approved Boya Bio-Pharmaceutical Group Co Ltd Mainland China Hemorrhage Boya Bio-Pharmaceutical Group Co Ltd 2020-12-02 Hemophilia B; Hemorrhage Details
Human prothrombin complex (Guangdong Wellen) Approved Guangdong Wellen Pharmaceutical Co Ltd Mainland China Hemorrhage Guangdong Wellen Pharmaceutical Co Ltd 2020-10-21 Hemophilia B; Hemorrhage Details
Human Coagulation Factor Ⅷ (Shanghai Raas Blood Products) Approved Shanghai Raas Blood Products Co Ltd Mainland China Hemophilia A Shanghai Raas Blood Products Co Ltd 1995-01-01 Hemophilia A Details
Factor IX (Bio Products Laboratory) Approved Bio Products Laboratory Ltd Replenine-VF United Kingdom Hemophilia B Bio Products Laboratory Ltd 1999-08-09 Hemophilia B Details
Human prothrombin complex (Lanzhou Lansheng Blood Products) Approved Lanzhou Lansheng Blood Products Co Ltd Mainland China Hemophilia B Lanzhou Lansheng Blood Products Co Ltd 2024-09-26 Hemophilia B Details
Human Coagulation Factor Ⅷ(Tonrol Bio-Pharmaceutical ) Approved Tonrol Bio-Pharmaceutical Co Ltd Mainland China Hemophilia A Tonrol Bio-Pharmaceutical Co Ltd 2013-08-23 Hemophilia A Details
Antithrombin III (Octapharma Ab) Approved Octapharma Ab Atenativ EU Antithrombin III Deficiency Octapharma Ab 2007-12-20 Antithrombin III Deficiency Details
Human prothrombin complex(Hebei Daan Pharmaceutical) Approved Hebei Daan Pharmaceutical Co Ltd Mainland China Hemorrhage Hebei Daan Pharmaceutical Co Ltd 2020-01-01 Hemophilia B; Hemorrhage Details
Human Coagulation Factor Ⅷ (Jiangxi Boya Bio-Pharmaceutical ) Approved Boya Bio-Pharmaceutical Group Co Ltd Mainland China Hemophilia A Boya Bio-Pharmaceutical Group Co Ltd 2022-08-08 Hemophilia A; Hemorrhage Details
Human Coagulation Factor Ⅷ (Guangdong Shuanglin Bio-Pharmaceutical) Approved Guangdong Shuanglin Bio-Pharmaceutical Co Ltd Mainland China Hemophilia A Guangdong Shuanglin Bio-Pharmaceutical Co Ltd 2020-06-17 Hemophilia A Details
Human coagulation factor Ⅷ (Shenzhen Weiguang Biological Products) Approved Shenzhen Weiguang Biological Products Co Ltd Mainland China Hemophilia A Shenzhen Weiguang Biological Products Co Ltd 2023-10-27 Hemophilia A Details
Polysulfonic mucopolysaccharide M-118102; M-1180B; M-7040B Approved Maruho Co Ltd 喜辽妥, 喜疗妥 Japan Thrombophlebitis; Arthritis; Cicatrix; Chilblains Maruho Co Ltd 1954-10-01 Phlebitis; Thrombophlebitis; Cicatrix; Chilblains; Contusions; Arthritis Details
Human coagulation factor VIII(Biotest Pharma Gmbh) Approved Biotest Pharma Gmbh Haemoctin SDH Hemophilia A Details
Human Coagulation Factor IX(China Biologic Products) Approved Shandong Taibang Biological Products Co Ltd Mainland China Hemophilia B Shandong Taibang Biological Products Co Ltd 2020-07-08 Hemophilia B Details
Factor IX (Sichuan Yuanda Shuyang Pharmaceutical) Approved Yuanda Shuyang Life Sciences (Chengdu) Co Ltd Mainland China Hemophilia B Yuanda Shuyang Life Sciences (Chengdu) Co Ltd 2023-02-14 Hemophilia B; Hemorrhage Details
Prothrombin complex concentrat (Taibang Biological Products) Approved Shandong Taibang Biological Products Co Ltd Mainland China Hemorrhage Shandong Taibang Biological Products Co Ltd 2014-09-30 Antithrombin III Deficiency; Hemorrhage Details
Human prothrombin complex (Hualan Biological Engineering) Approved Hualan Genetic Engineering Co Ltd Mainland China Factor X Deficiency; Blood Coagulation Disorders Hualan Biological Engineering Inc 1999-01-01 Blood Coagulation Disorders; Hemophilia B; Factor X Deficiency Details
Enoxaparin sodium biosimilar (Sahar International Trading) Approved Sahar International Trading Angina, Unstable; ST Elevation Myocardial Infarction; Venous Thromboembolism; Blood Coagulation Disorders Sahar International Trading 2013-07-01 Blood Coagulation Disorders; Angina, Unstable; ST Elevation Myocardial Infarction; Venous Thromboembolism Details
Human prothrombin complex concentrate (Shanxi Kangbao Biological Products) Approved Shanxi Kangbao Biological Product Co Ltd Mainland China Hemorrhage Shanxi Kangbao Biological Product Co Ltd 2019-09-17 Hemophilia B; Hemorrhage Details
Beroctocog alfa GC-1101; GC-1101C Approved GC Biopharma Corp GreenGene F South Korea Hemophilia A GC Biopharma Corp 2009-12-01 Hemophilia A Details
Damoctocog alfa pegol BAY-949027 Approved Bayer AG Jivi United States Hemophilia A Bayer Healthcare 2018-08-29 Hemophilia A; Hemorrhage Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Mim-8 NN 7769; Mim8; Mim-8; NNC0365-3769; NN7769; NN-7769; NNC0365-3769 A; NN0365-3769 Phase 3 Clinical Novo Nordisk A/S Hemophilia A Details
Recombinant factor VIII (Saman daroo 8) Phase 3 Clinical Saman Daroo 8 Hemophilia A Details
Human coagulation factor VIII (Jiangxi Boya Bio-pharmaceutical) Phase 3 Clinical Boya Bio-Pharmaceutical Group Co Ltd Hemophilia A Details
PEG-Recombinant FVIII-Fc fusion protein (Furen Medicines) FRSW-117 Phase 3 Clinical Kaifeng Pharmaceutical (Group) Co Ltd Blood Coagulation Disorders; Hemophilia A Details
Recombinant Human Coagulation Factor VIII(Nanjing Shunxin Pharmaceuticals) Phase 3 Clinical Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group Hemophilia A Details
Human Antithrombin III(Sichuan Yuanda Shuyang Pharma) Phase 3 Clinical Yuanda Shuyang Life Sciences (Chengdu) Co Ltd Thromboembolism; Antithrombin III Deficiency Details
Eptacog Alfa Biosimilar(Aryogen Pharmed) Phase 3 Clinical Aryogen Pharmed Co Hemophilia A; Factor VII Deficiency Details
Human prothrombin complex(Sinopharm Guizhou Plasma) Phase 3 Clinical Sinopharm Group Guizhou Bio-pharmaceutical Co Ltd Hemophilia B; Hemorrhage Details
Factor IX (Hualan Biological Engineering) Phase 3 Clinical Hualan Biological Engineering Inc Hemophilia B Details
Factor IX (Guangdong Shuanglin Bio-Pharmaceutical) Phase 3 Clinical Guangdong Shuanglin Bio-Pharmaceutical Co Ltd Hemophilia B Details
CT-001 (Coagulant Therapeutics) CT-001; CT001 Phase 3 Clinical Coagulant Therapeutics Corp Pain; Postpartum Hemorrhage Details
Ketamine/sufentanil nasal spray (Cessatech) CT-001 (Cessatech); CT-001 Phase 3 Clinical Cessatech A/S Anesthesia; Pain; Hemorrhage Details
Recombinant Human Coagulation Factor Ⅷ (Zhuangya Biotechnology) Phase 3 Clinical Zhuangya (Beijing) Biotechnology Co Ltd Hemophilia A Details
Human prothrombin complex concentrate (Sichuan Yuanda Shuyang Pharmaceutical) Phase 3 Clinical Yuanda Shuyang Life Sciences (Chengdu) Co Ltd Blood Coagulation Disorders Details
Dimolegin DD-217 Phase 3 Clinical Pharmadiall Ltd Venous Thromboembolism; Coronavirus Disease 2019 (COVID-19) Details
Human coagulation factor Ⅷ /Human von Willebrand factor (Shandong Taibang Biological Products) Phase 3 Clinical Shandong Taibang Biological Products Co Ltd von Willebrand Diseases; Hemophilia A; von Willebrand Disease, Type 1; Acquired hemophilia Details
Human prothrombin complex concentrate (Harbin Shiheng Bioengineering Pharmaceutical) Phase 3 Clinical Harbin Pacific Biopharmaceutical Co Ltd Hemophilia B Details
Recombinant human coagulation factor VIII-Fc fusion protein(Haimen Gensciences) FRSW-107 Phase 3 Clinical Jiangsu Gensciences lnc Blood Coagulation Disorders; Coagulation Protein Disorders; Hemophilia A; Hemorrhage; Blood Loss, Surgical Details
Human prothrombin complex(Sichuan Yuanda Shuyang Pharmceutical) Phase 3 Clinical Yuanda Shuyang Life Sciences (Chengdu) Co Ltd Hemophilia B; Hemorrhage Details
Human prothrombin complex(Hunan Ziguang Huhan Nanyue Pharmaceutical) Phase 3 Clinical Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd Hemophilia B Details
aPCC-emicizumab Phase 3 Clinical Emory University Hemophilia A Details
Human coagulation factor Ⅷ (Chengdu Institute Of Biological Products) Phase 3 Clinical Chengdu Institute Of Biological Products Co Ltd Hemophilia A Details
Ciraparantag PER-977 Phase 2 Clinical Perosphere Inc Hemorrhagic Disorders Details
Zifaxaban TY-602 Phase 2 Clinical Tianjin Remedy Research Institute Pulmonary Embolism; Venous Thrombosis Details
bemiltenase alfa STSP-0601 Phase 2 Clinical Staidson(Beijing) Biopharmaceuticals Co Ltd Hemorrhagic Disorders; Hemophilia A; Hemophilia B; Hemorrhage; Blood Loss, Surgical Details
Factor VIIa-CTP MOD-5014; MOD-5017; OPK88005 Phase 2 Clinical Opko Health Inc, Prolor Biotech Hemophilia A; Blood Coagulation Disorders, Inherited; Hemophilia B Details
Tearexaban TRx1 Phase 2 Clinical F. Hoffmann-La Roche Ltd Stroke; Venous Thrombosis Details
Recombinant human coagulation factor VIIa-Fc fusion protein(Jiangsu Gensciences) SS109; SS-109 Phase 2 Clinical Jiangsu Gensciences lnc Hemophilia A; Hemophilia B; Factor VII Deficiency Details
NXT-007 NXT-007; RG-6512; RO-7589655 Phase 2 Clinical Chugai Pharmaceutical Co Ltd Hemophilia A Details
R-1663 R-1663 Phase 1 Clinical F. Hoffmann-La Roche Ltd Thrombosis Details
SAR-107375-E SAR-107375-E; SAR-107375E Phase 1 Clinical Sanofi Venous Thrombosis Details
Eptacog alfa biosimilar (Valin Technologies) Phase 1 Clinical Valin Technologies Hemophilia A Details
Marzeptacog alfa CB-813; CB-813d; PF-5280602; PF-05280602 Phase 1 Clinical Catalyst Hemophilia A; Hemophilia B Details
Renaparin Phase 1 Clinical Vedanta Biosciences Inc Delayed Graft Function Details
WA1-089 WA1-089 Phase 1 Clinical North China Pharmaceutical Company Ltd Venous Thromboembolism Details
SYHA136 SYHA-136 Phase 1 Clinical CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd Venous Thromboembolism; Venous Thrombosis Details
NNC0442-0344 A NNC0442-0344 A; Inno8; NN7442 Phase 1 Clinical Novo Nordisk A/S Hemophilia A Details
Factor IX (Chengdu Rongsheng) Phase 1 Clinical Chengdu Rongsheng Pharmaceuticals Co Ltd Hemophilia B; Hemorrhage Details
Human prothrombin complex (National Drug Group Wuhan Blood) Phase 1 Clinical Sinopharm Wuhan Biopharmaceutical Co Ltd Hemorrhage Details
Recombinant FVIII-Fc fusion protein (Chengdu Rongsheng) Phase 1 Clinical Chengdu Rongsheng Pharmaceuticals Co Ltd Blood Coagulation Disorders; Hemophilia A Details
Rivaroxaban (Bio-synectics) BS-112 Phase 1 Clinical Bio-Synectics Inc Pulmonary Embolism; Venous Thrombosis Details
Rivaroxaban (Austhera Biosciences) AST-8294; DST-8294; KRIVA Phase 1 Clinical Dispersol Technologies Llc Antiphospholipid Syndrome Details
Human coagulation factor Ⅷ (Guizhou Taibang Biological Products) Phase 1 Clinical Guizhou Taibang Biological Products Co Ltd Details
CKD-344 CKD344; CKD-344 Phase 1 Clinical Chong Kun Dang Pharmaceutical Corp Details
Noxaban Phase 1 Clinical Zhaoke Pharmaceutical (Guangzhou) Co Ltd Venous Thromboembolism; Liver Cirrhosis Details
HR-17020 HR17020; HR-17020 Phase 1 Clinical Jiangsu Hengrui Medicine Co Ltd Venous Thromboembolism; Thromboembolism; Nephrotic Syndrome Details
GS001 GS-001 Clinical Institute Of Hematology & Blood Diseases Hospital Hemophilia A Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message